{"id":11358,"date":"2024-03-27T15:56:55","date_gmt":"2024-03-27T14:56:55","guid":{"rendered":"https:\/\/kloepfel.sempre-diritto.de\/2024\/03\/27\/novo-nordisk-kauft-deutsche-biotechfirma\/"},"modified":"2025-08-27T11:28:44","modified_gmt":"2025-08-27T09:28:44","slug":"novo-nordisk-rachete-une-entreprise-de-biotechnologie-allemande","status":"publish","type":"post","link":"https:\/\/kloepfel-consulting.com\/fr\/supply-chain-news\/novo-nordisk-kauft-deutsche-biotechfirma-11358\/","title":{"rendered":"Novo Nordisk ach\u00e8te une soci\u00e9t\u00e9 allemande de biotechnologie"},"content":{"rendered":"<h2>Plus d'un milliard d'euros pour l'acquisition de Cardior<\/h2>\n<p>Novo Nordisk acquiert la soci\u00e9t\u00e9 de biotechnologie Cardior Pharmaceuticals, bas\u00e9e \u00e0 Hanovre. Novo Nordisk renforce ainsi, selon ses propres dires <strong>Pipeline de produits<\/strong> dans le domaine des maladies cardio-vasculaires.<\/p>\n<p>Les deux entreprises ont annonc\u00e9 lundi qu'un accord avait \u00e9t\u00e9 conclu en ce sens. Selon cet accord, le prix d'achat s'\u00e9l\u00e8vera jusqu'\u00e0 1,025 milliard d'euros. Selon le communiqu\u00e9 de presse, cette somme comprend un paiement anticip\u00e9 et des paiements suppl\u00e9mentaires si certains objectifs sont atteints.<\/p>\n<p>Selon Novo Nordisk, Cardior est une entreprise leader en mati\u00e8re de <em>Recherche et d\u00e9veloppement <\/em>de th\u00e9rapies avec des m\u00e9dicaments \u00e0 base d'ARN pour le traitement des maladies cardiaques. Dans le cadre de la transaction, Novo Nordisk reprend \u00e9galement le produit phare de Cardior, appel\u00e9 CDR1321.<\/p>\n<p>Selon le communiqu\u00e9 de presse, ce m\u00e9dicament fait actuellement l'objet d'une \u00e9tude clinique de phase 2. Il est possible qu'il soit utilis\u00e9 \u00e0 l'avenir pour le traitement de l'insuffisance cardiaque.<\/p>\n<p>Comme l'explique Novo Nordisk dans son communiqu\u00e9 de presse, l'entreprise veut constituer un portefeuille de traitements contre les maladies cardiovasculaires gr\u00e2ce \u00e0 ses propres innovations et \u00e0 celles qu'elle ach\u00e8te. Selon le fabricant pharmaceutique danois, ces maladies sont la premi\u00e8re cause de mortalit\u00e9 dans le monde.<\/p>\n<p>La transaction est encore soumise \u00e0 l'obtention des autorisations r\u00e9glementaires. Les deux entreprises pr\u00e9voient de finaliser l'acquisition au deuxi\u00e8me trimestre 2024.<\/p>","protected":false},"excerpt":{"rendered":"<p>\u00dcber eine Milliarde Euro f\u00fcr die \u00dcbernahme von Cardior Novo Nordisk \u00fcbernimmt das in Hannover ans\u00e4ssige Biotechnologieunternehmen Cardior Pharmaceuticals. Damit st\u00e4rkt Novo Nordisk nach eigener Aussage seine Produktpipeline im Bereich der Herz-Kreislauf-Erkrankungen. Wie die beiden Unternehmen am Montag bekanntgaben, wurde eine entsprechende Vereinbarung getroffen. Demnach wird der Kaufpreis bis zu 1,025 Milliarden Euro betragen. In [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":11359,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[88],"tags":[],"referenzkategorie":[],"class_list":["post-11358","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-supply-chain-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Novo Nordisk kauft deutsche Biotechfirma<\/title>\n<meta name=\"description\" content=\"Novo Nordisk \u00fcbernimmt das in Hannover ans\u00e4ssige Biotechnologieunternehmen Cardior Pharmaceuticals. Damit st\u00e4rkt Novo Nordisk nach eigener\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/kloepfel-consulting.com\/fr\/actualites-de-la-chaine-dapprovisionnement\/novo-nordisk-achete-une-societe-de-biotechnologie-allemande-11358\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novo Nordisk kauft deutsche Biotechfirma\" \/>\n<meta property=\"og:description\" content=\"Novo Nordisk \u00fcbernimmt das in Hannover ans\u00e4ssige Biotechnologieunternehmen Cardior Pharmaceuticals. Damit st\u00e4rkt Novo Nordisk nach eigener Aussage seine Produktpipeline im Bereich der Herz-Kreislauf-Erkrankungen.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/kloepfel-consulting.com\/fr\/actualites-de-la-chaine-dapprovisionnement\/novo-nordisk-achete-une-societe-de-biotechnologie-allemande-11358\/\" \/>\n<meta property=\"og:site_name\" content=\"KLOEPFEL by EPSA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/KloepfelGroup\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-27T14:56:55+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-27T09:28:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/kloepfel-consulting.com\/wp-content\/uploads\/2025\/07\/kloepfelgroup.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"2200\" \/>\n\t<meta property=\"og:image:height\" content=\"1608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"semprediritto\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Novo Nordisk kauft Cardior Pharmaceuticals f\u00fcr 1 Milliarde Euro\" \/>\n<meta name=\"twitter:description\" content=\"Informieren Sie sich \u00fcber die \u00dcbernahme von Cardior durch Novo Nordisk.\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"semprediritto\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/supply-chain-news\\\/novo-nordisk-kauft-deutsche-biotechfirma-11358\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/supply-chain-news\\\/novo-nordisk-kauft-deutsche-biotechfirma-11358\\\/\"},\"author\":{\"name\":\"semprediritto\",\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/#\\\/schema\\\/person\\\/2691163984d9670e417622b00a4c0f26\"},\"headline\":\"Novo Nordisk kauft deutsche Biotechfirma\",\"datePublished\":\"2024-03-27T14:56:55+00:00\",\"dateModified\":\"2025-08-27T09:28:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/supply-chain-news\\\/novo-nordisk-kauft-deutsche-biotechfirma-11358\\\/\"},\"wordCount\":203,\"publisher\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/supply-chain-news\\\/novo-nordisk-kauft-deutsche-biotechfirma-11358\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/kloepfel-consulting.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/Novo-Nordisk-scaled-1.jpg\",\"articleSection\":[\"Supply Chain News\"],\"inLanguage\":\"fr-FR\",\"copyrightYear\":\"2024\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/fr\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/supply-chain-news\\\/novo-nordisk-kauft-deutsche-biotechfirma-11358\\\/\",\"url\":\"https:\\\/\\\/kloepfel-consulting.com\\\/supply-chain-news\\\/novo-nordisk-kauft-deutsche-biotechfirma-11358\\\/\",\"name\":\"Novo Nordisk kauft deutsche Biotechfirma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/supply-chain-news\\\/novo-nordisk-kauft-deutsche-biotechfirma-11358\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/supply-chain-news\\\/novo-nordisk-kauft-deutsche-biotechfirma-11358\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/kloepfel-consulting.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/Novo-Nordisk-scaled-1.jpg\",\"datePublished\":\"2024-03-27T14:56:55+00:00\",\"dateModified\":\"2025-08-27T09:28:44+00:00\",\"description\":\"Novo Nordisk \u00fcbernimmt das in Hannover ans\u00e4ssige Biotechnologieunternehmen Cardior Pharmaceuticals. Damit st\u00e4rkt Novo Nordisk nach eigener\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/supply-chain-news\\\/novo-nordisk-kauft-deutsche-biotechfirma-11358\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/kloepfel-consulting.com\\\/supply-chain-news\\\/novo-nordisk-kauft-deutsche-biotechfirma-11358\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/supply-chain-news\\\/novo-nordisk-kauft-deutsche-biotechfirma-11358\\\/#primaryimage\",\"url\":\"https:\\\/\\\/kloepfel-consulting.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/Novo-Nordisk-scaled-1.jpg\",\"contentUrl\":\"https:\\\/\\\/kloepfel-consulting.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/Novo-Nordisk-scaled-1.jpg\",\"width\":2560,\"height\":2560,\"caption\":\"Flaggen von Novo Nordisk, die im Wind wehen.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/supply-chain-news\\\/novo-nordisk-kauft-deutsche-biotechfirma-11358\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/kloepfel-consulting.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Supply Chain News\",\"item\":\"https:\\\/\\\/kloepfel-consulting.com\\\/category\\\/supply-chain-news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Novo Nordisk kauft deutsche Biotechfirma\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/#website\",\"url\":\"https:\\\/\\\/kloepfel-consulting.com\\\/\",\"name\":\"KLOEPFEL by EPSA\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/#organization\"},\"alternateName\":\"KLOEPFELbyEPSA\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/kloepfel-consulting.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/#organization\",\"name\":\"KLOEPFEL by EPSA\",\"alternateName\":\"KLOEPFELbyEPSA\",\"url\":\"https:\\\/\\\/kloepfel-consulting.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/kloepfel-consulting.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/logo.webp\",\"contentUrl\":\"https:\\\/\\\/kloepfel-consulting.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/logo.webp\",\"width\":616,\"height\":284,\"caption\":\"KLOEPFEL by EPSA\"},\"image\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/KloepfelGroup\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/kloepfel-consulting-gmbh\",\"https:\\\/\\\/www.instagram.com\\\/kloepfel_by_epsa\\\/\"],\"description\":\"Einkaufsberatung f\u00fcr Einkauf, Logistik und Supply Chain\",\"email\":\"info@kloepfel-consulting.com\",\"telephone\":\"+4921194198433\",\"legalName\":\"Kloepfel Consulting GmbH\",\"foundingDate\":\"2007-02-01\",\"vatID\":\"DE254132249\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":\"51\",\"maxValue\":\"200\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/#\\\/schema\\\/person\\\/2691163984d9670e417622b00a4c0f26\",\"name\":\"semprediritto\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/878f3ddb8fa2117ffa32d8a3152e4368517da61e3b89dd9bbfe39501477bf1f1?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/878f3ddb8fa2117ffa32d8a3152e4368517da61e3b89dd9bbfe39501477bf1f1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/878f3ddb8fa2117ffa32d8a3152e4368517da61e3b89dd9bbfe39501477bf1f1?s=96&d=mm&r=g\",\"caption\":\"semprediritto\"},\"sameAs\":[\"https:\\\/\\\/kloepfel.sempre-diritto.de\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Novo Nordisk ach\u00e8te une soci\u00e9t\u00e9 allemande de biotechnologie","description":"Novo Nordisk acquiert la soci\u00e9t\u00e9 de biotechnologie Cardior Pharmaceuticals, bas\u00e9e \u00e0 Hanovre. Novo Nordisk renforce ainsi, selon ses propres dires","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kloepfel-consulting.com\/fr\/actualites-de-la-chaine-dapprovisionnement\/novo-nordisk-achete-une-societe-de-biotechnologie-allemande-11358\/","og_locale":"fr_FR","og_type":"article","og_title":"Novo Nordisk kauft deutsche Biotechfirma","og_description":"Novo Nordisk \u00fcbernimmt das in Hannover ans\u00e4ssige Biotechnologieunternehmen Cardior Pharmaceuticals. Damit st\u00e4rkt Novo Nordisk nach eigener Aussage seine Produktpipeline im Bereich der Herz-Kreislauf-Erkrankungen.","og_url":"https:\/\/kloepfel-consulting.com\/fr\/actualites-de-la-chaine-dapprovisionnement\/novo-nordisk-achete-une-societe-de-biotechnologie-allemande-11358\/","og_site_name":"KLOEPFEL by EPSA","article_publisher":"https:\/\/www.facebook.com\/KloepfelGroup","article_published_time":"2024-03-27T14:56:55+00:00","article_modified_time":"2025-08-27T09:28:44+00:00","og_image":[{"width":2200,"height":1608,"url":"https:\/\/kloepfel-consulting.com\/wp-content\/uploads\/2025\/07\/kloepfelgroup.webp","type":"image\/webp"}],"author":"semprediritto","twitter_card":"summary_large_image","twitter_title":"Novo Nordisk kauft Cardior Pharmaceuticals f\u00fcr 1 Milliarde Euro","twitter_description":"Informieren Sie sich \u00fcber die \u00dcbernahme von Cardior durch Novo Nordisk.","twitter_misc":{"\u00c9crit par":"semprediritto","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/kloepfel-consulting.com\/supply-chain-news\/novo-nordisk-kauft-deutsche-biotechfirma-11358\/#article","isPartOf":{"@id":"https:\/\/kloepfel-consulting.com\/supply-chain-news\/novo-nordisk-kauft-deutsche-biotechfirma-11358\/"},"author":{"name":"semprediritto","@id":"https:\/\/kloepfel-consulting.com\/#\/schema\/person\/2691163984d9670e417622b00a4c0f26"},"headline":"Novo Nordisk kauft deutsche Biotechfirma","datePublished":"2024-03-27T14:56:55+00:00","dateModified":"2025-08-27T09:28:44+00:00","mainEntityOfPage":{"@id":"https:\/\/kloepfel-consulting.com\/supply-chain-news\/novo-nordisk-kauft-deutsche-biotechfirma-11358\/"},"wordCount":203,"publisher":{"@id":"https:\/\/kloepfel-consulting.com\/#organization"},"image":{"@id":"https:\/\/kloepfel-consulting.com\/supply-chain-news\/novo-nordisk-kauft-deutsche-biotechfirma-11358\/#primaryimage"},"thumbnailUrl":"https:\/\/kloepfel-consulting.com\/wp-content\/uploads\/2025\/08\/Novo-Nordisk-scaled-1.jpg","articleSection":["Supply Chain News"],"inLanguage":"fr-FR","copyrightYear":"2024","copyrightHolder":{"@id":"https:\/\/kloepfel-consulting.com\/fr\/#organization"}},{"@type":"WebPage","@id":"https:\/\/kloepfel-consulting.com\/supply-chain-news\/novo-nordisk-kauft-deutsche-biotechfirma-11358\/","url":"https:\/\/kloepfel-consulting.com\/supply-chain-news\/novo-nordisk-kauft-deutsche-biotechfirma-11358\/","name":"Novo Nordisk ach\u00e8te une soci\u00e9t\u00e9 allemande de biotechnologie","isPartOf":{"@id":"https:\/\/kloepfel-consulting.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/kloepfel-consulting.com\/supply-chain-news\/novo-nordisk-kauft-deutsche-biotechfirma-11358\/#primaryimage"},"image":{"@id":"https:\/\/kloepfel-consulting.com\/supply-chain-news\/novo-nordisk-kauft-deutsche-biotechfirma-11358\/#primaryimage"},"thumbnailUrl":"https:\/\/kloepfel-consulting.com\/wp-content\/uploads\/2025\/08\/Novo-Nordisk-scaled-1.jpg","datePublished":"2024-03-27T14:56:55+00:00","dateModified":"2025-08-27T09:28:44+00:00","description":"Novo Nordisk acquiert la soci\u00e9t\u00e9 de biotechnologie Cardior Pharmaceuticals, bas\u00e9e \u00e0 Hanovre. Novo Nordisk renforce ainsi, selon ses propres dires","breadcrumb":{"@id":"https:\/\/kloepfel-consulting.com\/supply-chain-news\/novo-nordisk-kauft-deutsche-biotechfirma-11358\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kloepfel-consulting.com\/supply-chain-news\/novo-nordisk-kauft-deutsche-biotechfirma-11358\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/kloepfel-consulting.com\/supply-chain-news\/novo-nordisk-kauft-deutsche-biotechfirma-11358\/#primaryimage","url":"https:\/\/kloepfel-consulting.com\/wp-content\/uploads\/2025\/08\/Novo-Nordisk-scaled-1.jpg","contentUrl":"https:\/\/kloepfel-consulting.com\/wp-content\/uploads\/2025\/08\/Novo-Nordisk-scaled-1.jpg","width":2560,"height":2560,"caption":"Flaggen von Novo Nordisk, die im Wind wehen."},{"@type":"BreadcrumbList","@id":"https:\/\/kloepfel-consulting.com\/supply-chain-news\/novo-nordisk-kauft-deutsche-biotechfirma-11358\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/kloepfel-consulting.com\/"},{"@type":"ListItem","position":2,"name":"Supply Chain News","item":"https:\/\/kloepfel-consulting.com\/category\/supply-chain-news\/"},{"@type":"ListItem","position":3,"name":"Novo Nordisk kauft deutsche Biotechfirma"}]},{"@type":"WebSite","@id":"https:\/\/kloepfel-consulting.com\/#website","url":"https:\/\/kloepfel-consulting.com\/","name":"KLOEPFEL by EPSA","description":"","publisher":{"@id":"https:\/\/kloepfel-consulting.com\/#organization"},"alternateName":"KLOEPFELbyEPSA","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kloepfel-consulting.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/kloepfel-consulting.com\/#organization","name":"KLOEPFEL by EPSA","alternateName":"KLOEPFELbyEPSA","url":"https:\/\/kloepfel-consulting.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/kloepfel-consulting.com\/#\/schema\/logo\/image\/","url":"https:\/\/kloepfel-consulting.com\/wp-content\/uploads\/2025\/04\/logo.webp","contentUrl":"https:\/\/kloepfel-consulting.com\/wp-content\/uploads\/2025\/04\/logo.webp","width":616,"height":284,"caption":"KLOEPFEL by EPSA"},"image":{"@id":"https:\/\/kloepfel-consulting.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/KloepfelGroup","https:\/\/www.linkedin.com\/company\/kloepfel-consulting-gmbh","https:\/\/www.instagram.com\/kloepfel_by_epsa\/"],"description":"Conseil d'achat pour l'approvisionnement, la logistique et la cha\u00eene d'approvisionnement","email":"info@kloepfel-consulting.com","telephone":"+4921194198433","legalName":"Kloepfel Consulting GmbH","foundingDate":"2007-02-01","vatID":"DE254132249","numberOfEmployees":{"@type":"QuantitativeValue","minValue":"51","maxValue":"200"}},{"@type":"Person","@id":"https:\/\/kloepfel-consulting.com\/#\/schema\/person\/2691163984d9670e417622b00a4c0f26","name":"Toujours le droit","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/878f3ddb8fa2117ffa32d8a3152e4368517da61e3b89dd9bbfe39501477bf1f1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/878f3ddb8fa2117ffa32d8a3152e4368517da61e3b89dd9bbfe39501477bf1f1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/878f3ddb8fa2117ffa32d8a3152e4368517da61e3b89dd9bbfe39501477bf1f1?s=96&d=mm&r=g","caption":"semprediritto"},"sameAs":["https:\/\/kloepfel.sempre-diritto.de"]}]}},"_links":{"self":[{"href":"https:\/\/kloepfel-consulting.com\/fr\/wp-json\/wp\/v2\/posts\/11358","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kloepfel-consulting.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kloepfel-consulting.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kloepfel-consulting.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kloepfel-consulting.com\/fr\/wp-json\/wp\/v2\/comments?post=11358"}],"version-history":[{"count":2,"href":"https:\/\/kloepfel-consulting.com\/fr\/wp-json\/wp\/v2\/posts\/11358\/revisions"}],"predecessor-version":[{"id":14750,"href":"https:\/\/kloepfel-consulting.com\/fr\/wp-json\/wp\/v2\/posts\/11358\/revisions\/14750"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kloepfel-consulting.com\/fr\/wp-json\/wp\/v2\/media\/11359"}],"wp:attachment":[{"href":"https:\/\/kloepfel-consulting.com\/fr\/wp-json\/wp\/v2\/media?parent=11358"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kloepfel-consulting.com\/fr\/wp-json\/wp\/v2\/categories?post=11358"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kloepfel-consulting.com\/fr\/wp-json\/wp\/v2\/tags?post=11358"},{"taxonomy":"referenzkategorie","embeddable":true,"href":"https:\/\/kloepfel-consulting.com\/fr\/wp-json\/wp\/v2\/referenzkategorie?post=11358"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}